Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-05-30

Clinical Trial Update: Lacosamide Intravenous Injection for Emergency Termination of Status Epilepticus

View source ↗

Summary

A clinical trial evaluating intravenous lacosamide for emergency termination of status epilepticus. The study is currently not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Lacosamide intravenous injection (lacosamide)

Snippet

Sponsor: Second Affiliated Hospital of Guangzhou Medical University | Conditions: Epilepsy, Status Epilepticus | Status: NOT_YET_RECRUITING